InVivo Therapeutics Corp:企業の製品パイプライン分析2018

◆英語タイトル:InVivo Therapeutics Corp - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12775
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaffold to treat acute SCI, and a biocompatible neuro spinal scaffold plus stem cells to treat chronic. InVivo offers treatment for mechanical injury directly disrupts axons, blood vessels, and cell membranes; and compressive-contusive-type injuries. The company provides services in the field of spinal cord injury. Its pipeline products comprise neuro-spinal scaffold, and bioengineered neural trails. InVivo is headquartered in Cambridge, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InVivo Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
InVivo Therapeutics Corp Company Overview 5
InVivo Therapeutics Corp Company Snapshot 5
InVivo Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
InVivo Therapeutics Corp – Pipeline Analysis Overview 7
InVivo Therapeutics Corp – Key Facts 7
InVivo Therapeutics Corp – Major Products and Services 8
InVivo Therapeutics Corp Pipeline Products by Development Stage 9
InVivo Therapeutics Corp Pipeline Products Overview 11
Dural Graft 11
Dural Graft Product Overview 11
Injectable Hydrogel – Fibrosis 12
Injectable Hydrogel – Fibrosis Product Overview 12
Injectable Hydrogel – Peripheral Nerve Pain 13
Injectable Hydrogel – Peripheral Nerve Pain Product Overview 13
Injectable Hydrogel Device – Acute SCI 14
Injectable Hydrogel Device – Acute SCI Product Overview 14
InVivoSeal 15
InVivoSeal Product Overview 15
Nerve Conduit 16
Nerve Conduit Product Overview 16
Neuro-Spinal Scaffold – Acute Complete Cervical SCI 17
Neuro-Spinal Scaffold – Acute Complete Cervical SCI Product Overview 17
Neuro-Spinal Scaffold – Acute Complete Thoracic SCI 18
Neuro-Spinal Scaffold – Acute Complete Thoracic SCI Product Overview 18
Neuro-Spinal Scaffold – Incomplete Thoracic & Cervical SCI 19
Neuro-Spinal Scaffold – Incomplete Thoracic & Cervical SCI Product Overview 19
Spinal Multi – Segmental Cell and Drug Delivery System 20
Spinal Multi – Segmental Cell and Drug Delivery System Product Overview 20
TrailMaker 21
TrailMaker Product Overview 21
InVivo Therapeutics Corp – Key Competitors 22
InVivo Therapeutics Corp – Key Employees 23
InVivo Therapeutics Corp – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
InVivo Therapeutics Corp, Recent Developments 25
May 02, 2018: InVivo Therapeutics Announces Presentation of Complete Six-Month Primary Endpoint Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury 25
Mar 19, 2018: InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the “CONTEMPO Registry Study”) Findings 25
Mar 08, 2018: InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold in Patients with Acute Spinal Cord Injury 26
Feb 05, 2018: InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer 26
Jan 03, 2018: InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward 27
Oct 10, 2017: InVivo Therapeutics Announces Oral Platform Presentation at 2017 Congress of Neurological Surgeons Annual Meeting 27
Sep 05, 2017: InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade 28
Aug 28, 2017: InVivo Therapeutics Announces Strategic Corporate Restructuring 28
Jul 31, 2017: InVivo Therapeutics Announces Updates on the INSPIRE Study 28
Jul 12, 2017: InVivo Therapeutics Announces Stanford Medicine as New Site for INSPIRE Study 30
Appendix 32
Methodology 32
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
InVivo Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
InVivo Therapeutics Corp Pipeline Products by Equipment Type 6
InVivo Therapeutics Corp Pipeline Products by Indication 6
InVivo Therapeutics Corp, Key Facts 7
InVivo Therapeutics Corp, Major Products and Services 8
InVivo Therapeutics Corp Number of Pipeline Products by Development Stage 9
InVivo Therapeutics Corp Pipeline Products Summary by Development Stage 10
Dural Graft - Product Status 11
Dural Graft - Product Description 11
Injectable Hydrogel - Fibrosis - Product Status 12
Injectable Hydrogel - Fibrosis - Product Description 12
Injectable Hydrogel - Peripheral Nerve Pain - Product Status 13
Injectable Hydrogel - Peripheral Nerve Pain - Product Description 13
Injectable Hydrogel Device - Acute SCI - Product Status 14
Injectable Hydrogel Device - Acute SCI - Product Description 14
InVivoSeal - Product Status 15
InVivoSeal - Product Description 15
Nerve Conduit - Product Status 16
Nerve Conduit - Product Description 16
Neuro-Spinal Scaffold - Acute Complete Cervical SCI - Product Status 17
Neuro-Spinal Scaffold - Acute Complete Cervical SCI - Product Description 17
Neuro-Spinal Scaffold - Acute Complete Thoracic SCI - Product Status 18
Neuro-Spinal Scaffold - Acute Complete Thoracic SCI - Product Description 18
Neuro-Spinal Scaffold - Incomplete Thoracic & Cervical SCI - Product Status 19
Neuro-Spinal Scaffold - Incomplete Thoracic & Cervical SCI - Product Description 19
Spinal Multi - Segmental Cell and Drug Delivery System - Product Status 20
Spinal Multi - Segmental Cell and Drug Delivery System - Product Description 20
TrailMaker - Product Status 21
TrailMaker - Product Description 21
InVivo Therapeutics Corp, Key Employees 23
Glossary 34

List of Figures
InVivo Therapeutics Corp Pipeline Products by Equipment Type 6
InVivo Therapeutics Corp Pipeline Products by Development Stage 9

★海外企業調査レポート[InVivo Therapeutics Corp:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • WSI Industries, Inc.:企業の戦略・SWOT・財務情報
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arrow Electronics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Arrow Electronics, Inc. Mergers …
  • ZIOPHARM Oncology Inc (ZIOP):企業財務及び戦略的SWOT分析
    Summary ZIOPHARM Oncology Inc (ZIOPHARM), formerly EasyWeb, Inc. is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to deliver safe, effective and scalable cell-based therapies for the treatment of cancer …
  • Petromanas Energy Inc. (PMI):企業概要、財務及び戦略的SWOT分析
    Summary Petromanas Energy Inc. (Petromanas), formerly WWI Resources Ltd., is an oil and gas company. The company, through its subsidiaries focuses on the exploration and development of oil and gas assets in Europe and Australia. Petromanas, through its wholly owned subsidiary, Petromanas Albania Gmb …
  • Per Aarsleff A/S:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Per Aarsleff A/S" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence …
  • Cincinnati Children’s Hospital Medical Center:(医療機器分野)企業M&A及び提携動向
    Summary Cincinnati Children's Hospital Medical Center (CCHMC) is a not-for-profit academic medical center. It is specialized in offering pediatric health care, research and education. The center serves the medical needs of children, adolescents and infants. It offers clinical services for the treatm …
  • General Cable Corporation:企業の戦略・SWOT・財務分析
    General Cable Corporation - Strategy, SWOT and Corporate Finance Report Summary General Cable Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Enterprise Products Partners LP (EPD)-エネルギー分野:企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • Ctac N.V. (CTAC):企業の財務及び戦略的SWOT分析
    Summary Ctac N.V. (Ctac) is an information technology company that provides content management and e-business solutions to various industrial sectors. The company offers services such as managed services, Ctac archiving-as-a-service, Ctac cloud services, test services, education and secondments. It …
  • Dorel Industries Inc.:企業の戦略・SWOT・財務情報
    Dorel Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Dorel Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • INRIX, Inc.:企業の戦略・SWOT・財務分析
    SummaryINRIX, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Halfords Group plc (HFD):企業の戦略的SWOT分析
    Halfords Group plc (HFD) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Ultrastroy Eood:企業の戦略的SWOT分析
    Ultrastroy Eood - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Impax Laboratories, Inc. (forme …
  • JSC Uralkali:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC Uralkali Mergers and Acquis …
  • United Orthopedic Corporation (4129):企業概要、財務及び戦略的SWOT分析
    Summary United Orthopedic Corporation (UOC) is a manufacturer of orthopedic instruments. The company designs, manufactures, and distributes medical equipments such as orthopedic implants, instruments and precision medical devices. Its product categories include hip replacement systems, knee replacem …
  • Saison Information Systems Co., Ltd. (9640):企業財務及び戦略的SWOT分析
    Summary Saison Information Systems Co., Ltd. (Saison Information Systems) is an information technology company that offers HULFT series and Bulas series. The company’s business activities include system development and operation business, and software package business. It offers services, which incl …
  • Altaba Inc.:企業のM&A・事業提携・投資動向
    Altaba Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altaba Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Opcon AB (OPCO):企業概要、財務及び戦略的SWOT分析
    Summary Opcon AB (Opcon) is an energy and environmental technology company. The company develops, produces and markets systems and products for energy consumption for customers in the process, power and engineering industries. Its renewable energy business concentrates on electricity generation base …
  • Connect Catering Limited :企業の戦略・SWOT・財務分析
    SummaryConnect Catering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆